Sulfur burps, like most gastrointestinal side effects of Wegovy, tend to be worse at the beginning of treatment and when increasing your dose
If shedding began 812 weeks after the biggest calorie deficit, it strongly suggests telogen effluvium , not direct GLP-1 hair loss
Autonomic neuropathy has been implicated as the major mechanism underlying DGP [33]
So its not as simple as slapping a GLP-1-friendly label on a product. Tate & Lyle is examining current full-dose users, consumers who are microdosing, former users, and people who have never taken the medication but want to lose weight
Backed by strong Phase 3 results, apitegromab is currently under FDA priority review, with a decision expected by September 22, 2025